The mechanism of BCG-induced protection is thought to be via a CD4+ Th1 type response, with evidence showing that BCG-specific IFN-γ response measured with ELISpot was associated with reduced TB disease risk over the early years of life31. This evidence concerns the gene CD4 and tuberculosis.